Visa enkel post

dc.contributor.authorWinther, Malene
dc.date.accessioned2017-01-20T09:53:24Z
dc.date.available2017-01-20T09:53:24Z
dc.date.issued2017-01-20
dc.identifier.isbn978-91-629-0065-6 (print)
dc.identifier.isbn978-91-629-0066-3 (PDF)
dc.identifier.urihttp://hdl.handle.net/2077/49484
dc.description.abstractG-protein-coupled receptors (GPCRs), which are the largest class of cell-surface receptors, are involved in a range of physiologic processes and pathologies, making this a highly interesting group of proteins as targets for drug development. Studies of these receptors have uncovered novel receptor biology concepts, including biased signaling, functional selectivity, and allosteric modulation. “Tailor-made” lipopeptides (pepducins and lipopeptoids) represent novel and promising classes of receptor-specific allosteric modulators. In this thesis, immunomodulating lipopeptides that interact with a group of pattern recognition receptors, formyl peptide receptors (FPRs), which play key roles in host defense against microbial infections, tissue homeostasis, and the initiation and resolution of inflammation, are generated and functionally characterized. The FPRs are expressed in both human and murine white blood cells, and novel allosteric lipopeptide modulators that selectively interact with human and murine receptors are described. We show that the targeted receptor is not always the one that might be expected. This receptor hijacking process raises questions about the precise mechanisms of action of these lipopeptides and of these types of molecules acting as a molecular pattern that is recognized by the receptor group studied. Fundamental differences are also revealed by the receptor-ligand recognition profiles, between mice and men. This represents important knowledge needed for the development and use of animal models for human diseases. In summary, the results presented in this thesis not only highlight the value of the different lipopeptides as tools for modulating receptor activities in human and murine immune cells, but also provide new insights into the allosteric modulation concept.sv
dc.language.isoengsv
dc.relation.haspartI. Winther M et al. Antibacterial activity of pepducins, allosterical modulators of formyl peptide receptor signaling. Antimicrob Agents Chemother. 2014 May 58(5):2985-8. ::PMID::24590483sv
dc.relation.haspartII. Winther M et al. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead. FEBS Lett. 2015 Jul 8;589(15):1832-9. ::PMID::26071379sv
dc.relation.haspartIII. Skovbakke SL et al. The peptidomimetic Lau-(Lys-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophils. Biochem Pharmacol. 2016 Nov 1;119:56-65. ::PMID::27614010sv
dc.relation.haspartIV. Winther M et al. pepducins from formyl peptide receptors allosterically modulate the function of the same receptor in human and murine neutrophils, but with an outcome (positive or negative) that is not dependent upon the origin of their receptor. manuscriptsv
dc.subjectHumansv
dc.subjectmousesv
dc.subjectneutrophilssv
dc.subjectreactive oxygen speciessv
dc.subjectformyl peptide receptorsv
dc.subjectpepducinssv
dc.subjectG-protein-coupled receptorsv
dc.subjectlipopeptoidsv
dc.subjectpattern recognition receptorsv
dc.titleFunctional Modulation of the Pattern Recognition Formyl Peptide Receptors in Neutrophils - Lipopeptides - allosteric modulators of G-protein coupled receptorssv
dc.typetexteng
dc.type.svepDoctoral thesiseng
dc.gup.mailmalene.winther@gu.sesv
dc.type.degreeDoctor of Philosophy (Medicine)sv
dc.gup.originUniversity of Gothenburg. Sahlgrenska Academysv
dc.gup.departmentInstitute of Medicine. Department of Rheumatology and Inflammation Researchsv
dc.gup.defenceplaceFredagen den 10 februari 2017, kl 9.00, föreläsningssalen våning 3, Guldhedsgatan 10A, Göteborgsv
dc.gup.defencedate2017-02-10
dc.gup.dissdb-fakultetSA


Filer under denna titel

Thumbnail
Thumbnail

Dokumentet tillhör följande samling(ar)

Visa enkel post